CS logo
small CS logo
St. Josef-Hospital, Klinik für Neurologie

Bochum, Germany
Neurological ward in Bochum, North Rhine-Westphalia
St. Josef-Hospital, Gudrunstraße 56, 44791 Bochum

About St. Josef-Hospital, Klinik für Neurologie


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
7
Charite University, Berlin, Germany
2
Newron Pharmaceuticals SPA
1
Total Rows: 3

Clinical Trials at St. Josef-Hospital, Klinik für Neurologie


During the past decade, St. Josef-Hospital, Klinik für Neurologie conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1111110011111100000000111100Started TrialsCompleted Trails201620172018201920202021202200.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safinamide in Levodopa Induced Dyskinesia in Parkinson's Disease Subjects
2010-04-01
2012-01-01
Completed
26
Effects of EGCG (Epigallocatechin Gallate) in Huntington's Disease (ETON-Study)
2011-09-01
2015-05-01
Completed
54
Apathy Cure Through Bupropion in Huntington's Disease
2012-06-01
2014-05-01
Completed
40
Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)
2014-02-20
2021-12-23
Completed
85
A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)
2016-09-09
2020-12-15
Completed
681
Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)
2017-03-24
2024-08-15
Active, not recruiting
1,239
Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)
2018-06-06
2023-02-17
Terminated
1,054
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)
2020-11-26
2029-03-30
Recruiting
865

Rows per page:

1–10 of 10

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "St. Josef-Hospital, Klinik für Neurologie" #1 collaborator was "Chugai Pharmaceutical" with 3 trials as a collaborator, "Ruhr University of Bochum" with 1 trials as a collaborator, "University Hospital Muenster" with 1 trials as a collaborator and "University of Ulm" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 7Hoffmann-La Roche: 7Charite University,Berlin, Germany: 2Charite University,Berlin, Germany: 2Newron Pharmaceuticals SPA: 1Newron Pharmaceuticals SPA: 1

Created with Highcharts 11.1.0Top CollaboratorsChugai Pharmaceutical: 3Chugai Pharmaceutical: 3Ruhr University of Bochum: 1Ruhr University of Bochum: 1University Hospital Muenster: 1University Hospital Muenster: 1University of Ulm: 1University of Ulm: 1

Clinical Trials Conditions at St. Josef-Hospital, Klinik für Neurologie


According to Clinical.Site data, the most researched conditions in "St. Josef-Hospital, Klinik für Neurologie" are "Multiple Sclerosis, Relapsing-Remitting" (2 trials), "Alzheimer Disease" (1 trials), "Apathy" (1 trials), "Generalized Myasthenia Gravis" (1 trials) and "Huntington Disease" (1 trials). Many other conditions were trialed in "St. Josef-Hospital, Klinik für Neurologie" in a lesser frequency.

Clinical Trials Intervention Types at St. Josef-Hospital, Klinik für Neurologie


Most popular intervention types in "St. Josef-Hospital, Klinik für Neurologie" are "Drug" (9 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Ocrelizumab" (3 trials), "Satralizumab" (3 trials), "(2)-epigallocatechin-3-gallate (EGCG)" (1 trials) and "Antihistamine" (1 trials). Other intervention names were less common.

Clinical Trials Genders at St. Josef-Hospital, Klinik für Neurologie


The vast majority of trials in "St. Josef-Hospital, Klinik für Neurologie" are 10 trials for "All" genders.

Clinical Trials Status at St. Josef-Hospital, Klinik für Neurologie


Currently, there are NaN active trials in "St. Josef-Hospital, Klinik für Neurologie". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in St. Josef-Hospital, Klinik für Neurologie, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in St. Josef-Hospital, Klinik für Neurologie, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 7Phase 3: 7Phase 2: 3Phase 2: 3

Created with Highcharts 11.1.0Trials StatusCompleted: 5Completed: 5Recruiting: 3Recruiting: 3Active, not recruiting: 1Active, not recruiting: 1Terminated: 1Terminated: 1